Contribution: Industrial Research Assistance Program – Contributions to Firms
Aetonix Systems Inc
$46,926.00
US Market Expansion
FY 2019-20 · 2019-04-01
Summary
Detail Market analysis of USA Healthcare organizations, in the North East of the United States, providing patient chronic care especially Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF) and for which the organizations are facing high 30-day readmission rates (above 20%).
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Ottawa|Ottawa, Ontario, Canada
Recipient Type
For-profit organization
Business Number
827242579
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-04-01 | 2019-20 | $46,926.00 |
| 1 | 2019-04-01 | 2019-20 | $46,926.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 32 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 32 jours.
Agreement End Date
2020-03-31
Agreement Number
927798
Agreement Start Date
2019-04-01
Agreement Title
US Market Expansion
Agreement Title (French)
Expansion du marché américain
Agreement Type
Contribution
Agreement Value
$46,926.00
Amendment Date
2020-01-21
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Detail Market analysis of USA Healthcare organizations, in the North East of the United States, providing patient chronic care especially Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF) and for which the organizations are facing high 30-day readmission rates (above 20%).
Description (French)
Analyse détaillée du marché des organisations américaines de soins de santé, dans le nord-est des États-Unis, qui fournissent des soins chroniques aux patients, en particulier la maladie pulmonaire obstructive chronique (MPOC) et l'insuffisance cardiaque congestive (ICC), et pour lesquelles les organisations font face à des taux élevés de réadmission à 30 jours (plus de 20 %).
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Ottawa Centre
Federal Riding (French)
Ottawa-Centre
Federal Riding Number
35075
NAICS Code
511211
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
827242579
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
Aetonix Systems Inc
Recipient Postal Code
K1Y 2C5
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2019-2020-Q1-927798
